Your browser doesn't support javascript.
loading
Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease.
Peretto, G; Sala, S; Benedetti, S; Di Resta, C; Gigli, L; Ferrari, M; Della Bella, P.
Afiliación
  • Peretto G; a Department of Cardiac Electrophysyology and Arrhythmology , IRCCS San Raffaele Hospital and University , Milan , Italy.
  • Sala S; a Department of Cardiac Electrophysyology and Arrhythmology , IRCCS San Raffaele Hospital and University , Milan , Italy.
  • Benedetti S; b Laboratory of Clinical Molecular Biology and Cytogenetics , IRCCS San Raffaele Hospital and University , Milan , Italy.
  • Di Resta C; c Genomic Unit for the diagnosis of human pathologies, Division of Genetics and Cellular Biology , IRCCS San Raffaele Hospital and University , Milan , Italy.
  • Gigli L; a Department of Cardiac Electrophysyology and Arrhythmology , IRCCS San Raffaele Hospital and University , Milan , Italy.
  • Ferrari M; b Laboratory of Clinical Molecular Biology and Cytogenetics , IRCCS San Raffaele Hospital and University , Milan , Italy.
  • Della Bella P; c Genomic Unit for the diagnosis of human pathologies, Division of Genetics and Cellular Biology , IRCCS San Raffaele Hospital and University , Milan , Italy.
Nucleus ; 9(1): 380-391, 2018.
Article en En | MEDLINE | ID: mdl-29929425
ABSTRACT
Cardiac laminopathies, associated with mutations in the LMNA gene, encompass a wide spectrum of clinical manifestations, involving electrical and mechanical alterations of cardiomyocytes. Thus, dilated cardiomyopathy, bradyarrhythmias and atrial or ventricular tachyarrhythmias may occur in a number of combined phenotypes. Nowadays, some attempt has been made to identify clinical predictors for the most life-threatening complications of LMNA-associated heart disease, i.e. sudden cardiac death and end-stage heart failure. The goal of this manuscript is to combine the most recent evidences in an updated review to show the state-of-the-art of such a complex disease group. This is supposed to be the starting point to collect more data and design new ad hoc studies to identify clinically useful predictors to stratify risk in mutation carriers, including probands and their asymptomatic relatives.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases Asunto principal: Enfermedades Musculoesqueléticas / Lamina Tipo A / Cardiopatías Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nucleus Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases Asunto principal: Enfermedades Musculoesqueléticas / Lamina Tipo A / Cardiopatías Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nucleus Año: 2018 Tipo del documento: Article País de afiliación: Italia
...